The overlap of cognitive impairment in depression and schizophrenia: A comparative study

Psychiatria Danubina

Volumn 23, Issue 3, 2011, Pages 251-256

  Šoštarič, Mojca ^a   Zalar, Bojan ^a  

^a University Psychiatric Clinic   (Slovenia)

Author keywords

Attention; Automatic processes; Cognitive impairment; Comparative study; Depression; Memory; Neurocognitive assessment; Schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION; COGNITIVE DEFECT; COMPARATIVE STUDY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; RECALL; SCHIZOPHRENIA; TASK PERFORMANCE; WORKING MEMORY;

ADULT; ATTENTION; CASE-CONTROL STUDIES; COGNITION DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SLOVENIA; TRAIL MAKING TEST; VERBAL LEARNING; YOUNG ADULT;

EID: 80054097654     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Austin MP, Mitchell P & Goodwin GM. Cognitive deficits in depression. Possible implications for junctional neuropathology. Br J Psychiatry 2001; 178:200-6. (Pubitemid 32183601)
2. Barch DM: The relationship among cognition, motivation, and emotion in schizophrenia: how much and how little we know. Schizophr Bull 2005; 31:875-81.
3. Bowie CR & Harvey P. Cognition in schizophrenia: impairments, determinants and functional importance. Psychiatr Clin North Am 2005; 28:613-33. (Pubitemid 41191137)
4. Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 2005; 31:5-19. (Pubitemid 41214353)
5. Chamberlain SR & Sahakian BJ. Cognition in mania and depression: psychological models and clinical implications. Curr Psychiatry Rep 2004; 6:451-58. (Pubitemid 41599919)
6. Chamberlain SR & Sahakian BJ. Neuropsychological assessment of mood disorders. Clin Neuropsychiatry 2005; 2:137-48.
7. Chepenik LG, Cornew LA & Farah MJ. The influence of sad mood on cognition. Emotion 2007; 7:802-11.
8. Ciesla JA & Roberts JE. Rumination, negative cognition, and their interactive effects on depressed mood. Emotion 2007; 7:555-65. (Pubitemid 47445356)
9. Crowe SF: Neuropsychological effects of the psychiatric disorders. Amsterdam: Harwood Academic Publishers, 1998:11-3.
10. Fava M: Symptoms of fatigue and cognitive / executive dysfunction in major depressive disorder before and after antidepressant treatment. J Clin Psychiatry 2003; 64:30-4.
11. Friedman MS, Bruder GE, Nestor PG, Stuart BK, Amador SX & Gorman JM. Perceptual asymmetries in schizophrenia: subtype differences in left hemisphere dominance for dichotic fused words. Am J Psychiatry 2001; 158:1437-40. (Pubitemid 32847242)
12. Green MF, Kern RS, Braff DL & Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the 'right stuff'. Schizophr Bull 2000; 26:119-36. (Pubitemid 30317696)
13. Green MF, Kern RS & Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 2004; 72:41-51. (Pubitemid 39452904)
14. Gualtieri CT, Johnson LG & Benedict KB. Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci 2006; 18:217-25.
15. Harvey PD: Cognition and the differential diagnosis in schizophrenia. World Psychiatry 2008; 7:30-2.
16. Häfner H: The early Kraepelin's dichotomy of schizophrenia and affective disorder - evidence of separate diseases? Eur J Psychiat 2010; 24:98-113.
17. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M & Könnecke S. Schizophrenia and depression: challenging the paradigm of two separate diseases - a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005; 77:11-24.
18. Keefe RSE: Should cognitive impairment be included in the diagnostic criteria for schizophrenia? World Psychiatry 2008; 7:22-8.
19. Keefe RSE & Fenton WS. How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull 2007; 33:912-20. (Pubitemid 47216649)
20. Lencz T, Smith CW, McLaughlin D, Authera A, Nakayama E, Hovey L & Comblait BA. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 2005; 59:863-71.
21. Maier W: Do schizoaffective disorders exist at all? Acta Psychiatr Scand 2006; 13:369-71.
22. Meyers JE & Meyers KR. Rey complex figure tests and recognition trial. Professional Manual. Lutz, Florida: Psychological Assessment Resources, 1995.
23. Morrens M, Hulstijn W, van Hecke J, Peuskens J & Sabbe BGC. Sensorimotor and cognitive slowing in schizophrenia as measured by the Symbol digit substitution test. J Psychiatr Res 2006; 40:684-92.
24. Morrens M, Hulstijn W & Sabbe B. Psychomotor slowing in schizophrenia. Schizophr Bull 2007; 33:1038-53. (Pubitemid 47216642)
25. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF & Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004; 72:29-39. (Pubitemid 39452903)
26. Palmer W, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ, Zisook S et al.: Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 1997; 11:437-46. (Pubitemid 27294667)
27. Reitan RM: Validity of the Trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8:271-6.
28. Schmidt M: Rey auditory verbal learning test: a handbook. Los Angeles: Western Psychological Services, 1996:1-3.
29. Strauss E, Sherman EM & Spreen O. A compendium of neuropsychological tests. Administration, norms and commentary. Oxford: University Press, Oxford, 2006.
30. Turetsky BI, Moberg PJ, Mozley LH, Moelter ST, Agrin RN, Gur RC & Gur RE. Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures. Neuropsychology 2002; 16:481-90.
31. Vanderhasselt MA & De Raedt R. Impairments in cognitive control persist during remission from depression and are related to the number of past episodes: an event related potentials study. Biol Psychol 2009; 81:169-76.
32. Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN & Buchanan RW. No, it is not possible to be schizophrenic yet neuropsychologically normal. Neuropsychology 2005; 19:778-86. (Pubitemid 41803524)
33. Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL & White OB. Negative symptoms: a review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull 2006; 70:312-21. (Pubitemid 44488719)
34. World Health Organization: The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization, 1993.
35. Zalewski C, Johnson-Selfridge MT, Ohriner S, Zarrella K & Seltzer JC. A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients. Schizophr Bull 1998; 24:127-45. (Pubitemid 28128494)